Novartis Debuts Rapidly Manufactured Autologous CAR-Ts

 
• By Alaric DeArment
  
3d illustration of T cells or cancer cells
Novartis unveiled early data on its two next-generation CAR-Ts, YTB323 and PHE885 • Source: Shutterstock

More from Immuno-oncology

More from Anticancer